Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 6Myeloid 5Lymphoid 4Plasma cell 2Other neoplasm 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 40Anemia, Refractory, with Excess of Blasts 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Leukemia, Lymphocytic, Chronic, B-Cell 28Myelodysplastic Syndromes 27Lymphoma, Non-Hodgkin 27Leukemia, Myelomonocytic, Chronic 27Hodgkin Disease 27Multiple Myeloma 24Primary Myelofibrosis 21Myeloproliferative Disorders 21Lymphoma, Follicular 21Leukemia 21Lymphoma 20Lymphoma, Mantle-Cell 19Congenital Abnormalities 19Leukemia, Myeloid, Chronic-Phase 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Anemia, Refractory 18Lymphoma, B-Cell, Marginal Zone 17Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Large-Cell, Immunoblastic 15Leukemia, Myeloid, Accelerated Phase 15Dendritic Cell Sarcoma, Interdigitating 13Neoplasms, Plasma Cell 12Recurrence 11Blast Crisis 11Anemia, Aplastic 11Leukemia, Myelomonocytic, Juvenile 10

Interventions

Mycophenolic Acid 2thymoglobulin 1nicotinamide-beta-riboside 1methanesulfonic acid 1fludarabine phosphate 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1RFT5-SMPT-dgA immunotoxin 1Peripheral Blood Stem Cell Transplantation 1Cyclosporine 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1Ascorbic Acid 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid × Mycophenolic Acid × Classical hematology × Clear all
NCT01760655 2025-10-30

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
62 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡